» Articles » PMID: 17237230

Identifying the Membrane Proteome of HIV-1 Latently Infected Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2007 Jan 24
PMID 17237230
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Profiling integral plasma membrane proteins is of particular importance for the identification of new biomarkers for diagnosis and for drug development. We report in this study the identification of surface markers by performing comparative proteomics of established human immunodeficiency virus-1 (HIV-1) latent cell models and parental cell lines. To this end we isolated integral membrane proteins using a biotin-directed affinity purification method. Isolated proteins were separated by two-dimensional gel electrophoresis and identified by matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) after in gel digestion. Seventeen different proteins were found to vary on the surface of T-cells due to HIV-1 infection. Of these proteins, 47% were integral membrane proteins, and 18% were membrane-associated. Through the use of complementary techniques such as Western blotting and fluorescent staining, we confirmed the differential expression of some of the proteins identified by MALDI-TOF including Bruton's tyrosine kinase and X-linked inhibitor of apoptosis. Finally, using phosphatidylinositol 3-kinase inhibitors and flavopiridol to inhibit Bruton's tyrosine kinase localization at the membrane and X-linked inhibitor of apoptosis protein expression, respectively, we showed that HIV-1 latently infected cells are more sensitive to these drugs than uninfected cells. This suggests that HIV-1 latently infected cells may be targeted with drugs that alter several pathways that are essential for the establishment and maintenance of latency.

Citing Articles

A Primer on Proteomic Characterization of Intercellular Communication in a Virus Microenvironment.

Kostas J, Brainard C, Cristea I Mol Cell Proteomics. 2025; 24(3):100913.

PMID: 39862905 PMC: 11889360. DOI: 10.1016/j.mcpro.2025.100913.


iTRAQ-based proteomic study on monocyte cell model discovered an association of LAMP2 downregulation with HIV-1 latency.

Yin L, Wang Q, Liu S, Chen J, Zhang Y, Lu L Proteome Sci. 2024; 22(1):6.

PMID: 38750478 PMC: 11095035. DOI: 10.1186/s12953-024-00230-3.


Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules.

Kadiyala G, Telwatte S, Wedrychowski A, Janssens J, Kim S, Kim P AIDS. 2024; 38(9):1281-1291.

PMID: 38626436 PMC: 11216394. DOI: 10.1097/QAD.0000000000003908.


Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine.

Ur Rehman S, Ullah N, Zhang Z, Zhen Y, Din A, Cui H Front Chem. 2024; 11:1335330.

PMID: 38274897 PMC: 10809404. DOI: 10.3389/fchem.2023.1335330.


Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure.

Duggan N, Dragic T, Chanda S, Pache L Viruses. 2023; 15(12).

PMID: 38140676 PMC: 10747579. DOI: 10.3390/v15122435.